Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2018 | HM-PRO: collecting specific QoL and symptom data for hematological malignancies

Esther Oliva • 14 Jun 2018
EHA 2018
General

Quality of life and symptom data are essential for informing treatment plans as a clinician, as Esther Oliva, MD, Chair of the European Haematology Association Scientific Working Group (EHA-SWG), from the Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy, discusses at the 23rd Congress of the European Hematology Association (EHA) 2018, held in Stockholm, Sweden. As of yet, there is no specific instrument for collecting such data from patients with hematological malignancies. Dr Oliva gives an overview of the content and potential for a specific instrument such as this, and outlines why such a resource is needed.

More from Esther Oliva

1:26
Treatment benefits for elderly AML patients with azacitidine
Esther Oliva • 14 Jun 2018
0:49
Developing a patient-reported outcome instrument for Gaucher disease
Esther Oliva • 14 Jun 2018
3:38
A new set of treatment options for low-risk MDS
Esther Oliva • 14 Jun 2018

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals